Carlyle Group’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-9,620
| Closed | -$224K | – | 27 |
|
|
2024
Q4 | $224K | Hold |
9,620
| – | – | 0.01% | 25 |
|
|
2024
Q3 | $282K | Hold |
9,620
| – | – | 0.03% | 25 |
|
|
2024
Q2 | $227K | Hold |
9,620
| – | – | 0.02% | 27 |
|
|
2024
Q1 | $365K | Hold |
9,620
| – | – | 0.02% | 28 |
|
|
2023
Q4 | $204K | Buy |
+9,620
| New | +$204K | 0.01% | 23 |
|
|
2023
Q3 | – | Sell |
-9,620
| Closed | -$108K | – | 26 |
|
|
2023
Q2 | $108K | Hold |
9,620
| – | – | ﹤0.01% | 25 |
|
|
2023
Q1 | $69K | Buy |
+9,620
| New | +$69K | ﹤0.01% | 30 |
|